Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US29479A1088
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00MTSR883
ERAS
Erasca Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Erasca Inc
ISIN
US29479A1088
TICKER
ERAS
MIC
XNAS
REUTERS
ERAS.OQ
BLOOMBERG
ERAS US
Fr., 19.06.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 19.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 19.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 19.06.2026       Erasca
US29479A1088

SAN FRANCISCO, June 19, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 18, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the “Class Period”), have until August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit. Captioned Cheng v. Erasc...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Class...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

Time-Sensitive: Allegations Focus on Concealed Patient Death and Misleading Cross-Study Comparisons in ERAS-0015 Phase 1 TrialNEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt alerts investors in Erasca, Inc. (NASDAQ: ERAS) of a pending securities class action. Class Period: January 14, 2025 through April 26, 2026. Check if you can recover your in...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 18.06.2026       Erasca
US29479A1088

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourage...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 18.06.2026       Erasca
US29479A1088

Philadelphia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Cla...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

Law Offices of Howard G. Smith reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”).IF YOU ARE AN INVESTOR WHO S...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 17, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

Erasca's repeated preclinical comparisons to Revolution Medicines' RMC-6236 were allegedly improper and placed the company at risk of patent and trade secret violations, costing investors over $11 per share when the truth emerged.NEW YORK, June 17, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Erasca, Inc. (NASDAQ: ERAS) tha...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

SAN DIEGO, June 17, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"), have until August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. (“Erasca” or the “Company”) (NasdaqGS: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Erasca, Inc. who were adversely affected...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 17.06.2026       Erasca
US29479A1088

SAN FRANCISCO, June 16, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

NEW YORK, June 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). A class...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Clas...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 16.06.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

NEW YORK, June 16, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

NEW YORK, June 16, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Erasca, Inc. (NASDAQ: ERAS). Shareholders who purchased shares of ERAS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appoint...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

San Diego, California--(Newsfile Corp. - June 16, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"), have until August 10, 2026 to seek appointment as lead plaintiff of the Erasca class...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 16.06.2026       Erasca
US29479A1088

SAN DIEGO, June 15, 2026 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 15.06.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 15.06.2026       Erasca
US29479A1088

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”). Erasca investors have until August 10, 2026 to file a lead plaintiff motion.IF YOU...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 14.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 14, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 14.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 13.06.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - June 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 13.06.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 13.06.2026       Erasca
US29479A1088

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”), have until August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit. Captioned Cheng v. Erasca, Inc., No...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ERASCA, INC....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

Law Offices of Howard G. Smith announces an investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ERASCA, INC. (ERAS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAI...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Cla...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. (“Erasca” or “the Company”) (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

NEW YORK, June 11, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"). A class...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ:ERAS) securities during the period of January 14, 2025 through April 26, 2026, inclusive (“the Class Period”). If you suffered a loss on your Erasca investments, you have un...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 12.06.2026       Erasca
US29479A1088

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the “Class Period”). Erasca develops oncology therapies. For more information, submit a form, email attorney Phillip Kim, or give us a c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 11.06.2026       Erasca
US29479A1088

SAN DIEGO, June 11, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), have until August 10, 2026 to seek appointment as lead plaintiff of the Erasca class action lawsuit. Captioned...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 11.06.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Erasca, Inc (“Erasca” or the “Company”) (NASDAQ: ERAS) and reminds investors of the August 10, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This press release...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 11.06.2026       Erasca
US29479A1088

The Law Offices of Frank R. Cruz announces an investigation of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ERASCA, INC. (ERAS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YO...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 11.06.2026       Erasca
US29479A1088

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients wi...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 04.06.2026       Erasca
US29479A1088

SAN FRANCISCO, June 4, 2026 /PRNewswire/ -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the price of their shares tank  $9.25 (-48%) on April 28, 2026 after the company announced that it is facing a legal challenge to intellectual property claims for its lead product candidate (ERAS-0015).  The challenge is being waged by competitor Revolution Me...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 28.05.2026       Erasca
US29479A1088

SAN FRANCISCO, May 28, 2026 /PRNewswire/ -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the price of their shares tank  $9.25 (-48%) on April 28, 2026 after the company announced that it is facing a legal challenge to intellectual property claims for its lead product candidate (ERAS-0015).  The challenge is being waged by competitor Revolution Me...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 21.05.2026       Erasca
US29479A1088

NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 21.05.2026       Erasca
US29479A1088

SAN FRANCISCO, May 21, 2026 /PRNewswire/ -- Investors in Erasca, Inc. (NASDAQ: ERAS) saw the price of their shares tank  $9.25 (-48%) on April 28, 2026 after the company announced that it is facing a legal challenge to intellectual property claims for its lead product candidate (ERAS-0015).  The challenge is being waged by competitor Revolution Me...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 20.05.2026       Erasca
US29479A1088

The law firm of Kirby McInerney LLP continues its investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ:ERAS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happe...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 15.05.2026       Erasca
US29479A1088

NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink